World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
29866
World Ranking
16469
National Ranking
179

Ole Schmitz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ole Schmitz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 347 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ole Schmitz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ole Schmitz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ole Schmitz is affiliated with Aarhus University Hospital in Denmark. Their academic profile reflects involvement in medical or clinical research, as indicated by this primary institutional connection.

No recent papers, co-authors, specific publication venues, book publications, or detailed fields of study have been listed in the available data. Consequently, there is no detailed record of the scientist's research outputs, research collaborations, or thematic specializations accessible at this time.

Similarly, no explicit main fields, subfields, or specific research topics have been provided, so it is not possible to delineate their areas of expertise or research focus beyond the association with Aarhus University Hospital.

There is no information about awards or recognitions received by Ole Schmitz, nor any indication of deceased status, so the profile uses present tense and maintains a neutral and factual tone as per guidelines.

Best Publications

  • Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

    John A. Dormandy;Bernard Charbonnel;David J A Eckland;Erland Erdmann

  • Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

    D. Russell-Jones;A. Vaag;O. Schmitz;B. K. Sethi

  • Effect of valsartan on the incidence of diabetes and cardiovascular events.

    John McMurray;R Holman;Steven Haffner;M Bethel

  • Liraglutide, a Long-Acting Human Glucagon-Like Peptide-1 Analog, Given as Monotherapy Significantly Improves Glycemic Control and Lowers Body Weight Without Risk of Hypoglycemia in Patients With Type 2 Diabetes

    Tina Vilsbøll;Milan Zdravkovic;Tu Le-Thi;Thure Krarup

  • Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin

    S Lund;G D Holman;O Schmitz;O Pedersen

  • One Week’s Treatment With the Long-Acting Glucagon-Like Peptide 1 Derivative Liraglutide (NN2211) Markedly Improves 24-h Glycemia and α- and β-Cell Function and Reduces Endogenous Glucose Release in Patients with Type 2 Diabetes

    Kristine B. Degn;Claus B. Juhl;Jeppe Sturis;Grethe Jakobsen

  • Effect of nateglinide on the incidence of diabetes and cardiovascular events

    Rury R. Holman;Steven M. Haffner;Steven M. Haffner;John J. McMurray;M. Angelyn Bethel;M. Angelyn Bethel

  • Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial.

    Sten Madsbad;Ole Schmitz;Jonas Ranstam;Grethe Jakobsen

  • Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants

    Yingrui Li;Nicolas Vinckenbosch;Geng Tian;Emilia Huerta-Sanchez

  • Bedtime Administration of NN2211, a Long-Acting GLP-1 Derivative, Substantially Reduces Fasting and Postprandial Glycemia in Type 2 Diabetes

    Claus B. Juhl;Malene Hollingdal;Jeppe Sturis;Grethe Jakobsen

  • Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects

    Andrea Mari;Ole Schmitz;Amalia Gastaldelli;Torben Oestergaard

  • Effect of Intravenous Infusion of Exenatide (Synthetic Exendin-4) on Glucose-Dependent Insulin Secretion and Counterregulation During Hypoglycemia

    Kristine B. Degn;Birgitte Brock;Claus B. Juhl;Christian B. Djurhuus

  • Studies of association of variants near the HHEX , CDKN2A/B and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects – validation and extension of genome-wide association studies

    Niels Grarup;Chrisian S. Rose;Ehm A. Andersson;Gitte Andersen

  • Long-Term AICAR Administration Reduces Metabolic Disturbances and Lowers Blood Pressure in Rats Displaying Features of the Insulin Resistance Syndrome

    Esben S. Buhl;Niels Jessen;Rasmus Pold;Thomas Ledet

  • GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes.

    Bo Ahrén;O Schmitz

  • Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans.

    C. B. Djurhuus;C. H. Gravholt;S. Nielsen;A. Mengel

  • Liraglutide, a once‐daily human GLP‐1 analogue, improves pancreatic B‐cell function and arginine‐stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus

    Tina Vilsbøll;B Brock;Hans Perrild;K Levin

  • Amylin Agonists: A Novel Approach in the Treatment of Diabetes

    Ole Schmitz;Birgitte Brock;Jorgen Rungby

  • Pulsatile Insulin Secretion: Detection, Regulation, and Role in Diabetes

    Niels Pørksen;Malene Hollingdal;Claus Juhl;Peter Butler

  • Chronic treatment with 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner

    Esben S. Buhl;Niels Jessen;Ole Schmitz;Steen B. Pedersen

Frequent Co-Authors

Niels Møller
Niels Møller Aarhus University
Oluf Pedersen
Oluf Pedersen University of Copenhagen
Hans Ørskov
Hans Ørskov Aarhus University Hospital
Hans Erik Bøtker
Hans Erik Bøtker Aarhus University Hospital
Jens Otto Lunde Jørgensen
Jens Otto Lunde Jørgensen Aarhus University Hospital
Steen B. Pedersen
Steen B. Pedersen Aarhus University Hospital
Bjørn Richelsen
Bjørn Richelsen Aarhus University
Jens J. Holst
Jens J. Holst University of Copenhagen
Torben Hansen
Torben Hansen University of Copenhagen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine involves numerous pathways, many of which can now be started online. For students interested in nursing, there are entry level MSN programs online designed for non-nurses. These programs allow candidates with a non-nursing background to rapidly transition into advanced nursing roles through an accelerated curriculum.

If you are concerned about admission challenges, you may want to investigate what is the easiest nursing school to get into. These institutions often have flexible requirements, making it easier for students to start their healthcare education.

Those drawn to healthcare administration or record keeping can look at medical billing and coding schools that accept financial aid. These programs are ideal for students seeking in-demand, stable roles that support healthcare systems behind the scenes.

Some nursing schools are also removing barriers by offering admission without standardized entrance tests. If you wish to avoid additional exams, consider a nursing school that doesn't require teas exam. This provides greater access and flexibility for aspiring nurses to enter the field.

Best Scientists Citing Ole Schmitz

Recently Published Articles